hTERT Promoter Methylation Status in Peripheral Blood Leukocytes as a Molecular Marker of Head and Neck Cancer Progression

Journal of Applied Genetics - Germany
doi 10.1007/s13353-018-0458-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

HYAL2 Methylation in Peripheral Blood as a Potential Marker for the Detection of Pancreatic Cancer – A Case Control Study

Oncotarget
Oncology
2017English

Age-Related Changes in DNA Methylation Status of hTERT Gene Promoter of Oral Epithelial Cells

Brazilian Archives of Biology and Technology
2014English

Similar Blood-Borne DNA Methylation Alterations in Cancer and Inflammatory Diseases Determined by Subpopulation Shifts in Peripheral Leukocytes

British Journal of Cancer
Cancer ResearchOncology
2014English

Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients

SpringerPlus
Multidisciplinary
2015English

The Molecular Pathogenesis of Head and Neck Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

An Investigation of the Availability of CYFRA21-1 as a Tumor Marker in Head and Neck Cancer.

Practica Otologica
Otorhinolaryngology
1997English

Molecular Biology and Immunology of Head and Neck Cancer

Surgical Oncology Clinics of North America
SurgeryOncology
2015English

Publisher Correction: The Molecular Landscape of Head and Neck Cancer

Nature Reviews Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy